Recent advances in our understanding of human host responses to tuberculosis
- PMID: 11686880
- PMCID: PMC2002073
- DOI: 10.1186/rr53
Recent advances in our understanding of human host responses to tuberculosis
Abstract
Tuberculosis remains one of the world's greatest public health challenges: 2 billion persons have latent infection, 8 million people develop active tuberculosis annually, and 2-3 million die. Recently, significant advances in our understanding of the human immune response against tuberculosis have occurred. The present review focuses on recent work in macrophage and T-cell biology that sheds light on the human immune response to tuberculosis. The role of key cytokines such as interferon-gamma is discussed, as is the role of CD4+ and CD8+ T cells in immune regulation in tuberculosis, particularly with regard to implications for vaccine development and evaluation.
References
-
- Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science. 1991;254:277–279. - PubMed
-
- Modlin RL. Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol. 1994;102:828–832. - PubMed
-
- Glickman MS, Cox JS, Jacobs WR. A novel mycolic acid cyclopropane synthetase is required for coding, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell. 2000;5:717–727. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
